ALL-438 Minimal Residual Disease–Negative Complete Remission at the End of Induction Is a Prognostic Indicator of Long-Term Survival in Adult Patients With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Receiving First-Line Therapy
Ashaye A, Chalandon Y, Boissel N, Fazioli K, Wang B, Aldoss I, Huang F, Leonard J, Szabo N, McCloskey C, Nair S, Dalal M, Hennessy M, Yeh T, Martinelli G, Badar T, Kantarjian H, Ribera J, Jabbour E. ALL-438 Minimal Residual Disease–Negative Complete Remission at the End of Induction Is a Prognostic Indicator of Long-Term Survival in Adult Patients With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Receiving First-Line Therapy. Clinical Lymphoma Myeloma & Leukemia 2024, 24: s270-s271. DOI: 10.1016/s2152-2650(24)01111-x.Peer-Reviewed Original ResearchMinimal residual diseasePh+ acute lymphoblastic leukemiaAcute lymphoblastic leukemiaMRD-negative CRFirst-line therapyLong-term EFSIndividual patient dataComplete remissionFirst-lineMRD analysisLymphoblastic leukemiaPrognostic indicatorAdult patientsPrognostic indicators of long-term survivalDiagnosed Ph+ ALLPhiladelphia chromosome-positive acute lymphoblastic leukemiaMinimal residual disease levelsMinimal residual disease statusMRD-negative complete remissionIndicators of long-term survivalIndividual patient data analysisAchievement of CRStudy-level meta-analysisKaplan-Meier methodLog-rank test